Innospec (IOSP) has drawn attention after recent share price pressure, including a 1 day return of about 0.9% and a decline of roughly 6.5% over the past month.
At a last close of US$76.37, the specialty chemicals group now sits modestly below some estimates of intrinsic value. This has prompted investors to revisit how its fuel additives, performance chemicals, and oilfield services businesses are contributing to current fundamentals.
See our latest analysis for Innospec.
Looking beyond the recent weakness, Innospec’s share price return over the past 90 days is slightly positive, yet its 1 year total shareholder return shows a decline. This suggests sentiment has cooled even as investors reassess the risk and growth profile of its specialty chemicals and oilfield exposure.
If this has you thinking about where else capital might work harder, it could be a good moment to scan our list of 18 top founder-led companies as potential fresh ideas.
With the share price under pressure, a roughly 20% 1 year total return decline, and a value score of 5 alongside a modest intrinsic discount, is Innospec quietly offering a buying opportunity, or is the market already pricing in future growth?
With Innospec’s fair value narrative sitting at $99.33 against a last close of $76.37, the story centers on whether current earnings and cash generation justify that gap under a 7.37% discount rate.
The updated analyst price target for Innospec is now $99.33. Analysts point to adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E as the key drivers behind this revised view.
Valuation Changes
Want to see what sits under that $99.33 fair value tag? The narrative leans on expectations of revenue expansion, more conservative margins, and a higher future earnings multiple. Curious how those moving parts fit together to support an undervaluation view at today’s price?
Result: Fair Value of $99.33 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are clear risks here, including pressure on margins from raw material costs and potential revenue weakness in Oilfield Services if key customers pull back.
Find out about the key risks to this Innospec narrative.
Given the mix of caution and optimism in this article, it makes sense to move quickly, review the underlying data, and decide where you stand. To help with that, take a look at the 6 key rewards and see which positives investors are currently focused on.
If this Innospec update has sharpened your focus, do not stop here, the next move often comes from the ideas you almost skipped past.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English